1. Home
  2. Live Updates
  3. சிலிக்கான் சிகிச்சை

சிலிக்கான் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சிலிக்கான் சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சிலிக்கான் சிகிச்சை Today - Breaking & Trending Today

Roivant Sciences Reports First Fiscal Quarter 2021 Financial Results and Provides Business Update

Roivant Sciences Reports First Fiscal Quarter 2021 Financial Results and Provides Business Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Matthew Gline , Paul Davis , Roivant Sciences Ltd , Roivant Sciences Forward , Rhine Merger Sub Inc , Ciox Health , Development Expenses , Montes Archimedes Acquisition Corp , Roivant Sciences , Securities Exchange , Oncopia Therapeutics Inc , Chief Executive Officer , Fiscal Quarter , Silicon Therapeutics , Oncopia Therapeutics , Consolidated Statements , Months Ended June , Securities Act , Securities Exchange Act , Business Combination Agreement , Montes Archimedes Acquisition , Rhine Merger Sub , Risk Factors , நகரம் ஆஃப் ,

Roivant Sciences Reports First Fiscal Quarter 2021 Financial Results and Provides Business Update

Roivant Sciences Reports First Fiscal Quarter 2021 Financial Results and Provides Business Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Matthew Gline , Paul Davis , Roivant Sciences Ltd , Roivant Sciences Forward , Rhine Merger Sub Inc , Ciox Health , Development Expenses , Montes Archimedes Acquisition Corp , Roivant Sciences , Securities Exchange , Oncopia Therapeutics Inc , Chief Executive Officer , Fiscal Quarter , Silicon Therapeutics , Oncopia Therapeutics , Consolidated Statements , Months Ended June , Securities Act , Securities Exchange Act , Business Combination Agreement , Montes Archimedes Acquisition , Rhine Merger Sub , Risk Factors , நகரம் ஆஃப் ,

Roivant's move to go public reveals just how much its drug strategy has changed


Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy. ....

New York , United States , Sumitomo Dainippon Pharma , Vivek Ramaswamy , Matthew Gline , Montes Archimedes Acquisition Corp , Roivant Sciences , Fidelity Management Research Company , Softbank Group , Switzerland Based Roivant , Montes Archimedes , Sio Gene , Silicon Therapeutics , Fidelity Management , Research Company , Eventide Asset Management , Suvretta Capital , Palantir Technologies , Viking Global Investors , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , விவேக் ராமசாமி , மேத்யூ கிளினே , மான்டஸ் ஆர்க்கிமிடீஸ் கையகப்படுத்தல் கார்ப் , றொய்வன்ட் அறிவியல் , நம்பகத்தன்மை மேலாண்மை ஆராய்ச்சி நிறுவனம் ,

Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology


More from AP ....

United States , Menlo Park , City Of , United Kingdom , Sumitomo Dainippon Pharma , Vivek Ramaswamy , Zach Kouwe Doug Allen , Jim Momtazee , Matthew Gline , Paul Davis , Jp Morgan Securities , Roivant Sciences Overview , Davis Polk Wardwell , Fidelity Management Research Company , Softbank Group Corp , Kirkland Ellis , Truist Securities Inc , Exchange Commission , Roivant Sciences , Prnewswire Roivant Sciences , Montes Archimedes Acquisition Corp , Goldman Sachs Co , Citigroup Global Markets Inc , Montes Archimedes Acquisition , Patient Square Capital , Fidelity Management ,

(MAAC), (ABUS) - Roivant Sciences Gets SPAC Deal: What To Expect From This BioPharma, Health Technology Company


Share:
A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning.
The SPAC Deal: Roviant Sciences announced a SPAC deal with
Montes Archimedes Acquisition Corp (NASDAQ: MAAC). The deal values the company at an enterprise value of $5 billion.
A $200 million PIPE is backed by companies including Softbank Group Corp., Fidelity Management & Research Co., Sumitomo Dainippon Pharma and
Palantir Technologies Inc (NYSE: PLTR).
Shares of the new company will trade as ROIV on the Nasdaq with an anticipated closing date in the third quarter.
A percentage of current ownership shares will have a three-year lock-up and earn-outs based on $15 and $20 price points. Current Montes Archimedes acquisition shareholders will own 5.6% of the company after the merger. ....

Sumitomo Dainippon Pharma , Sumitomo Dainippon , Fidelity Management Research Co , Softbank Group Corp , Sio Gene Therapies Inc , Arbutus Biopharma Corp , Montes Archimedes Acquisition Corp , Immunovant Inc , Roviant Sciences , Palantir Technologies Inc , Fidelity Management , Montes Archimedes , Silicon Therapeutics , நம்பகத்தன்மை மேலாண்மை ஆராய்ச்சி இணை , சாப்ட் பேங்க் குழு கார்ப் , சிோ கீந் சிகிச்சைகள் இன்க் , மான்டஸ் ஆர்க்கிமிடீஸ் கையகப்படுத்தல் கார்ப் , நம்பகத்தன்மை மேலாண்மை , மான்டஸ் ஆர்க்கிமிடீஸ் , சிலிக்கான் சிகிச்சை ,